Kevin H Chen

Kevin H Chen

Boston University - Boston / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 847602
person_outline Kevin H Chen's MOST POPULAR ARTICLES
1-) Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor Leukemia 31 (10), 2151-2160, 2017
2-) First-in-human CLL1-CD33 compound CAR T cell therapy induces complete remission in patients with refractory acute myeloid leukemia: update on phase 1 clinical trial Blood 132, 901, 2018
3-) Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies Oncotarget 7 (35), 56219, 2016
4-) Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia Leukemia 32 (6), 1317-1326, 2018
5-) Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells Oncotarget 8 (68), 112783, 2017